INS and type 2 diabetes mellitus: Initiation of basal insulin in adults with type 2 diabetes (T2D) has been linked to improvements in health-related quality of life (HRQoL) [1–5], though anxiety regarding self-injection and complicated dosing regimens continues to burden patients [6].